About Mercury Laboratories Limited
Data last updated:
Mercury Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 February 1982 and has been in existence for over 44 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L74239MH1982PLC026341. Its GSTIN is 27AAACM0414D2Z5 (Maharashtra). The company holds 10 GST registrations, of which 8 are active. Its shares are listed on BSE: 538964.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹1.2 Cr. It was formerly known as Mercury Laboratories Private Limited. It is led by directors including Rajendrakumar Ramanlal Shah (Managing Director) and Paresh Jagdishbhai Mistry.
Its last annual general meeting (AGM) was held on 13 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shreeji Mang Idas Marketprincess Street, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2025, the company reported a revenue of ₹76.17 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹3.14 Cr (net margin 4.1%) and EBITDA of ₹7.02 Cr (EBITDA margin 9.2%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 6% over five years.
The company has about 471 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Mercury Laboratories. As per MCA filings, the company has open charges of ₹35.71 Cr and satisfied charges of ₹33.61 Cr on record. Court records list 66 cases involving the company, including 36 filed by the company and 25 filed against it; 13 cases are pending. The company has 1 deal on record (1 market trade); the latest was in May 2023. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Asence Pharma Private Limited. The company has 5 MSME Form 1 returns on record between 2019 and 2021, listing 616 overdue payments to 33 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mercurylabs.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressShreeji Mang Idas Marketprincess Street, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mercury Laboratories Limited
The main business activity of Mercury Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mercury Laboratories Limited FY 2025 filings available
Mercury Laboratories Limited reported revenue of ₹76.17 Cr (down 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Mercury Laboratories Limited
Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mercury Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹76.17 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.02 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.14 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mercury Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mercury Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mercury Laboratories Limited
Mercury Laboratories Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asence Pharma Private Limited | •••• | •••• | •••• | •••• | 77 | Vadodara, Gujarat, India |
| Vasa Pharma Chem Pvt Ltd | •••• | •••• | •••• | •••• | 112 | Ahmedabad, Gujarat, India |
| Vapi Care Pharma Private Limited | •••• | •••• | •••• | •••• | 109 | Vapi, Valsad, Gujarat, India |
| Aritex Industries Private Limited | •••• | •••• | •••• | •••• | - | Ludhiana, Punjab, India |
| Eskag Pharma Pvt Ltd | •••• | •••• | •••• | •••• | 654 | Kolkata, West Bengal, India |
| Mercury Laboratories Limited this company | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Vovantis Laboratories Private Limited | •••• | •••• | •••• | •••• | 157 | Vadodara, Gujarat, India |
| Higlance Laboratories Private Limited | •••• | •••• | •••• | •••• | 421 | New Delhi, Delhi, India |
| Vital Therapeutics and Formulations Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Bennet Pharmaceuticals Limited | •••• | •••• | •••• | •••• | - | Vadodara, Gujarat, India |
| Rusoma Laboratories Private Limited | •••• | •••• | •••• | •••• | 128 | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Mercury Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Mercury Laboratories Limited
Mercury Laboratories Limited is audited by NARESH AND CO for the financial year 2025.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NARESH AND CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mercury Laboratories Limited
Mercury Laboratories has 6 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendrakumar Ramanlal Shah | Managing Director | 16 Feb 1982 | 44 Years 7 Months | Current |
| Paresh Jagdishbhai Mistry | Director | 01 Oct 2017 | 9 Years 0 Months | Current |
| Dilip Ramanlal Shah | Director | 16 Feb 1982 | 44 Years 7 Months | Current |
| Janki Rajendra Shah Also directs: Mercury Antibiotics LLP | Director | 05 Feb 2020 | 6 Years 8 Months | Current |
| Sanjay Patel Also directs: Ace Blue Ventures LLP, Aromix Private Limited, Multidimensional Holdings and Consultants Private Limited and 3 more | Director | 14 May 2025 | 1 Years 4 Months | Current |
| Jayantilal Dhaneshwar Raval | Director | 24 Jul 2024 | 2 Years 2 Months | Current |
Ownership and Shareholding of Mercury Laboratories Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mercury Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Mar 2026 | Sidbi | ₹18 Cr | Open |
| 19 Dec 2024 | Sidbi | ₹1.9 Cr | Open |
| 14 Mar 2024 | Hdfc Bank Limited | ₹20 Lakh | Open |
| 25 May 2023 | Hdfc Bank Limited | ₹50 Lakh | Open |
| 27 Sep 2021 | Hdfc Bank Limited | ₹7.06 Cr | Open |
Total charge records: 19 View all charges
Deals & Funding of Mercury Laboratories Limited
Mercury Laboratories Limited has 1 deal on record (1 market trade); the latest was in May 2023.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2023 | Market trade | ₹1.55 Cr | Buyer: an individual Seller: an individual |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Mercury Laboratories Limited
Mercury Laboratories Limited has 66 court cases on record: 36 filed by Mercury Laboratories, 25 filed against it, 5 where it is another party. 13 cases are pending and 53 are disposed. Status as checked between 28 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 39 | 20 | 9 |
| High courts | 26 | 4 | 4 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 66)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Commercial matter | Filed against the company by Radiant Parenterals Limited | Disposed |
| District court, Vadodara, Gujarat | Court case (SPCS) | Filed by the company against Asoj Soft Caps Pvt Ltd | Disposed |
| District court, Bharatpur, Rajasthan | Court case (Complaint) | Filed against the company by State of Rajasthan | Pending |
| District court, Rangareddy, Telangana | Criminal complaint | Filed against the company by State of Telangana | Pending |
| District court, Kamrup Metro, Assam | Court case (Complaint Case C.R.) | Filed against the company by Union of India | Pending |
Full case history
All 66 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Mercury Laboratories Limited
Mercury Laboratories Limited has 5 MSME Form 1 returns on record between 2019 and 2021, listing 616 overdue payments to 33 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 33)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 5 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Mercury Laboratories Limited
Mercury Laboratories operates one associated brand: Mercury Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical drugs are manufactured by Mercury Laboratories in India. | mercurylabs.com |
Employees and EPFO Compliance at Mercury Laboratories Limited
Mercury Laboratories Limited has a workforce of 471 employees as of Oct 10, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Mercury Laboratories Limited
Mercury Laboratories has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74239MH1982PLC026341, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L74239MH1982PLC026341 | Current |
| U74239MH1982PTC026341 | Previous |
| U74239MH1982PLC026341 | Previous |
News related to Mercury Laboratories Limited
Recent Activity on Mercury Laboratories Limited
Mercury Laboratories Limited has 24 board changes on record since 1982: 15 appointments and 9 cessations. The latest: Bharat Dhirajlal Mehta ceased to be Director on 14 May 2025.
56 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Mercury Laboratories Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mercury Laboratories Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mercury Laboratories Limited
Mercury Laboratories has 10 GST registrations: 8 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACM0414D2Z5 | Maharashtra | Active | 14 Dec 2017 |
| 09AAACM0414D1Z4 | Uttar Pradesh | Active | 01 Jul 2017 |
| 24AAACM0414D1ZC | Gujarat | Active | 01 Jul 2017 |
| 33AAACM0414D1ZD | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mercury Laboratories Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mercury Laboratories Limited
Mercury Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 February 1982 (44+ years old) and is registered under CIN L74239MH1982PLC026341. Listed on BSE: 538964.
Mercury Laboratories reported revenue of ₹76.17 Cr for FY 2025 (down 1% YoY).
Mercury Laboratories has 6 current directors:
- Rajendrakumar Ramanlal Shah - Managing Director
- Paresh Jagdishbhai Mistry - Director
- Dilip Ramanlal Shah - Director
- Janki Rajendra Shah - Director
- Sanjay Patel - Director
- Jayantilal Dhaneshwar Raval - Director
Mercury Laboratories reported a net profit of ₹3.14 Cr (net margin 4.1%) and EBITDA of ₹7.02 Cr (EBITDA margin 9.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mercury Laboratories is 9% over three years and 6% over five years. In the latest year (FY 2025) revenue fell 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mercury Laboratories is 27AAACM0414D2Z5, registered in Maharashtra. The company has 10 GST registrations in all, of which 8 are active and 2 are cancelled or inactive. Other active GSTINs include 09AAACM0414D1Z4 (Uttar Pradesh), 24AAACM0414D1ZC (Gujarat), 33AAACM0414D1ZD (Tamil Nadu).
The CIN (Corporate Identification Number) of Mercury Laboratories is L74239MH1982PLC026341. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Mercury Laboratories is listed on BSE with code 538964.
Mercury Laboratories has 66 court cases on record: 36 filed by the company and 25 filed against it. 13 are pending. Most are in the district courts.
Mercury Laboratories was incorporated on 12 February 1982, making it 44+ years old. It is registered with the Registrar of Companies, Mumbai.
Mercury Laboratories has 1 deal on record (1 market trade); the latest was in May 2023.
The peers of Mercury Laboratories by revenue are Asence Pharma Private Limited, Vasa Pharma Chem Pvt Ltd, Vapi Care Pharma Private Limited, Aritex Industries Private Limited, Eskag Pharma Pvt Ltd and 5 more, all in the Pharma industry (Formulations).